BIBR 277SE en es it fr

BIBR 277SE Brand names, BIBR 277SE Analogs

BIBR 277SE Brand Names Mixture

  • No information avaliable

BIBR 277SE Chemical_Formula

C7H9ClO6P2S

BIBR 277SE RX_link

http://www.rxlist.com/cgi/generic2/tiludronate.htm

BIBR 277SE fda sheet

BIBR 277SE msds (material safety sheet)

BIBR 277SE Synthesis Reference

No information avaliable

BIBR 277SE Molecular Weight

318.609 g/mol

BIBR 277SE Melting Point

No information avaliable

BIBR 277SE H2O Solubility

No information avaliable

BIBR 277SE State

Solid

BIBR 277SE LogP

0.549

BIBR 277SE Dosage Forms

Tablets for oral administration containing 240 mg tiludronate disodium

BIBR 277SE Indication

For treatment of Paget's disease of bone (osteitis deformans).

BIBR 277SE Pharmacology

Tiludronate is a first generation (non-nitrogenous) bisphosphonate in the same family as etidronate and clodronate. Tiludronate affects calcium metabolism and inhibits bone resorption and soft tissue calcification. Of the tiludronate that is resorbed (from oral preparation) or infused (for intravenous drugs), about 50% is excreted unchanged by the kidney. The remainder has a very high affinity for bone tissue, and is rapidly absorbed onto the bone surface.

BIBR 277SE Absorption

The mean oral bioavailability in healthy male subjects is 6% after an oral dose equivalent to 400 mg tiludronic acid administered after an overnight fast and 4 hours before a standard breakfast. In single-dose studies, bioavailability was reduced by 90% when an oral dose equivalent to 400 mg tiludronic acid was administered with, or 2 hours after, a standard breakfast compared to the same dose administered after an overnight fast and 4 hours before a standard breakfast.

BIBR 277SE side effects and Toxicity

Based on the known action of tiludronate, hypocalcemia is a potential consequence of overdose. In one patient with hypercalcemia of malignancy, intravenous administration of high doses (800 mg/day total dose, 6 mg/kg/day for 2 days) was associated with acute renal failure and death.

BIBR 277SE Patient Information

BIBR 277SE Organisms Affected

Humans and other mammals